Literature DB >> 16280109

Update: NCCN prostate cancer Clinical Practice Guidelines.

Peter Scardino1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16280109

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  24 in total

Review 1.  Radical prostatectomy as primary treatment of high-risk prostate cancer.

Authors:  Alexandre Ingels; Alexandre de la Taille; Guillaume Ploussard
Journal:  Curr Urol Rep       Date:  2012-04       Impact factor: 3.092

2.  Prediction of mortality after radical prostatectomy by Charlson comorbidity index.

Authors:  Thomas J Guzzo; Paul Dluzniewski; Ryan Orosco; Elizabeth A Platz; Alan W Partin; Misop Han
Journal:  Urology       Date:  2010-09       Impact factor: 2.649

Review 3.  Prostate cancer in senior adults: over- or undertreated?

Authors:  Ingrid Berger; Franz Böhmer; Anton Ponholzer; Stephan Madersbacher
Journal:  Wien Med Wochenschr       Date:  2009

4.  Impact of comorbidity on survival among men with localized prostate cancer.

Authors:  Peter C Albertsen; Dirk F Moore; Weichung Shih; Yong Lin; Hui Li; Grace L Lu-Yao
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

5.  Statin use is associated with decreased prostate cancer recurrence in men treated with brachytherapy.

Authors:  Daniel S Oh; Bridget Koontz; Stephen J Freedland; Leah Gerber; Pretesh Patel; Stephen Lewis; David S Yoo; James Oleson; Joseph K Salama
Journal:  World J Urol       Date:  2014-03-27       Impact factor: 4.226

6.  Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy.

Authors:  Ofer Yossepowitch; Scott E Eggener; Angel M Serio; Brett S Carver; Fernando J Bianco; Peter T Scardino; James A Eastham
Journal:  Eur Urol       Date:  2007-10-12       Impact factor: 20.096

7.  Brachytherapy for prostate cancer: a systematic review.

Authors:  Georgios Koukourakis; Nikolaos Kelekis; Vassilios Armonis; Vassilios Kouloulias
Journal:  Adv Urol       Date:  2009-09-01

8.  Who benefits from hypofractionated radiation therapy for clinically localized prostate cancer: evidence from meta-analysis.

Authors:  Libin Sun; Linbin Sun; Shimiao Zhu; Yang Zhao; Hui Zhang; Zhiqun Shang; Ning Jiang; Gang Li; Yuanjie Niu
Journal:  Tumour Biol       Date:  2014-07-06

9.  Patterns of bone mineral density testing in men receiving androgen deprivation for prostate cancer.

Authors:  Vahakn B Shahinian; Yong-Fang Kuo
Journal:  J Gen Intern Med       Date:  2013-05-14       Impact factor: 5.128

10.  Survival in prostate cancer patients > or = 70 years after radical prostatectomy and comparison to younger patients.

Authors:  Jesco Pfitzenmaier; Sascha Pahernik; Stephan Buse; Axel Haferkamp; Nenad Djakovic; Markus Hohenfellner
Journal:  World J Urol       Date:  2009-04-26       Impact factor: 4.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.